PDUFA Dates: “Make-Or-Break Catalysts” For Biotech Stocks In October
Drugs for pain management, migraines, dry eye disease and Ebola are among those with PDUFA dates – deadlines by which the FDA must review new…
Drugs for pain management, migraines, dry eye disease and Ebola are among those with PDUFA dates – deadlines by which the FDA must review new…
While today’s article was written before the election and its shocking upset, the author had the foresight to ignore the polls, pundits and public expectations…
With yield-starved investors flocking to dividend-paying stocks, the question becomes whether these high-demand stocks are becoming overvalued. While the analysts cited in today’s article acknowledge…